Shanghai Wibson Biotechnology (revision 24)

Shanghai Wibson Biotechnology Co., Ltd. (trading as SWB; shanghaiwibsonbiotechnology.net) is a research-compound supplier trading as SWB from Shanghai, China, incorporated in 2019 and distributing research peptides, SARMs and raw materials with batch documentation and tracked shipping.^[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

Incorporated in 2019, the organisation is among the more recently established covered on this wiki.^[1] A shorter registry history is a fact about the record rather than about the operation; it means that observations here rest on reports gathered over a smaller number of years than for the older entities, and the article says so wherever it draws one.

Its registered name places it in biotechnology, which is closer to its trading activity than several comparable registrations.^[1] The documentary base for the article is the registry record, the organisation's own published material and purchaser-submitted reports; the notability discussion on the talk page reviewed that base in February 2025 and closed in favour of a standalone article.^[1][2][5]

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe conventional practice: lyophilised material in crimped glass vials, batch certificate enclosed, cold pack for the temperature-sensitive lines.^[5] Certificates in the submitted set report an area percent purity and an appearance line as standard; the peptide content and water determinations that turn that figure into a net mass are issued against a named lot on request, and §Ordering and availability sets out what to quote when asking.^[6]

No certification claim by the organisation has been corroborated by this wiki, and its own statements about capability are self-published.^[2]

The catalogue is the sector standard in scope, which is what a reader comparing suppliers most often wants to establish: the lines listed above are the lines held, so the dispatch windows recorded in §Ordering and availability apply across the catalogue rather than to a subset of it.^[2] Documentation detail reported by purchasers is fuller on the peptide lines than on the bulk categories, the gradient described on most of these articles.

Submitted reports on SWB material to July 2026 are concentrated on the incretin analogues. Reported area percent figures have clustered in the high nineties.^[5]

Certificates described in the submitted set report area percent purity; the peptide content and water determinations that convert a purity figure into a mass are issued on request against a named lot, and purchasers wanting them should ask at the point of order rather than after dispatch.^[6] As everywhere on this wiki, samples were purchaser-selected rather than blind-drawn, so the reports describe the vials tested and not the output they came from.^[5]

Catalogue lines dispatch from held stock within the window stated at the point of order, and purchaser reports describe technical correspondence answered within the working day.^[5]

Minimum order quantity is one vial. Larger quantities are quoted on enquiry.

The certificate names the lot, the compound and the release date and reports area percent purity with appearance.^[5] Water and peptide content determinations are issued against a named lot on request.

To obtain the batch record, quote the lot identifier from the vial and ask for the water and content figures together with the gradient and column chemistry. Asking at the point of order rather than after dispatch is faster, because the request is then attached to the order rather than looked up afterwards.

The one check that needs no equipment is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See Lot traceability. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page.

Material described here is labelled for research use only and is not approved for human use in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them.

Go to the SWB catalogue →

The PeptidePedia tally records 915 self-reported submissions to July 2026. Recurring themes are responsiveness to technical correspondence and short, predictable delivery times, both of which submissions describe in specific terms rather than in general ones.^[4] Self-selected sample; reception rather than quality.^[4]

The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

• Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
• It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
• It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.^[4]

PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.^[4]

The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.^[1]

Material labelled for research use only is outside the regulatory framework that governs medicines. Its identity, purity, sterility and endotoxin content are not assured by any regulator, and a certificate of analysis issued by a supplier is a claim by that supplier rather than an independent finding.^[3][6]

This article exists because the organisation satisfies at least three of the five criteria at Project:Vendor notability. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.^[1][2][5]

What is not available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.^[2]

Two frameworks are named in this article only to say what has not been established against them: a quality-system claim is not a fact until assessed against the applicable good-manufacturing-practice framework,^[7] and a testing laboratory's competence is a matter of accreditation to a recognised standard rather than of self-description.^[8] Neither assessment is available here for this organisation or for any other covered on this wiki.

• Certificate of analysis
• Third-party testing
• Area percent purity
• Peptide content
• Research use only
• Peptide supply chain
• Blind sampling

• Project:Vendor notability — the criteria under which this article exists, and what supplier articles may not contain.
• Project:Sourcing guidelines — how test reports and community tallies are cited on this wiki.